首页 > 最新文献

International Journal of Diabetes in Developing Countries最新文献

英文 中文
Cardiovascular autonomic neuropathy and charcot neuroarthropathy in type 2 diabetes: adding a new severity classification score 2 型糖尿病患者的心血管自主神经病变和 charcot 神经性关节病:新增严重程度分类分数
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2024-03-11 DOI: 10.1007/s13410-024-01328-2
Jessica Castro de Vasconcelos, Yeelen Ballesteros Atala, Denise Engelbrecht Zantut-Wittmann, Maria Cândida Ribeiro Parisi

Objective

This study aimed to assess the presence and characteristics of cardiovascular autonomic neuropathy (CAN) in people with type 2 diabetes with and without Charcot neuroarthropathy (CN).

Background

Diabetes can affect nerves in many ways beyond sensitive neuropathy.

Methods

A cross-sectional study was carried out in people with diabetes and CN who were matched for sex and age with two groups of people with diabetes without CN. All subjects underwent CAN assessment with seven tests (four Ewing tests and three bands of spectral analysis), and a severity score was constructed using these seven tests (each altered test equivalent to 1 point).

Results

Of the 69 people evaluated, 49 (71%) had incipient or installed CAN. A total of 95.2% of people with Charcot neuroarthropathy had incipient or installed CAN. There was a higher prevalence of dyslipidemia among people with installed autonomic neuropathy than among those with incipient CAN or without CAN. Thirty-four (69%) people with CAN had increased urinary albumin excretion. The severity score, constructed from the seven tests used for the diagnosis of CAN, revealed a greater number of altered tests and higher scores among people with CN when compared to the other participants, indicating greater severity of the condition.

Conclusions

There is a high prevalence of CAN in people with type 2 diabetes followed in a tertiary health service and the use of severity score may enable to differentiate people with or without CN. We suggest that this score could be used as a new tool in caring for people with diabetes to identify the most severe CAN.

本研究旨在评估伴有或不伴有 Charcot 神经性关节病(CN)的 2 型糖尿病患者中是否存在心血管自主神经病变(CAN)及其特征。背景糖尿病会以多种方式影响神经,而不仅仅是敏感性神经病变。方法对伴有 CN 的糖尿病患者和两组不伴有 CN 的糖尿病患者进行横断面研究,这两组患者的性别和年龄相匹配。所有受试者都通过七项测试(四项尤因测试和三段频谱分析)对 CAN 进行了评估,并通过这七项测试得出了严重程度评分(每项改变的测试相当于 1 分)。共有 95.2% 的夏科神经关节病患者患有初期或已安装的 CAN。在患有自律神经病的患者中,血脂异常的发病率要高于初发或未安装 CAN 的患者。34名(69%)自律神经病患者的尿白蛋白排泄量增加。根据用于诊断 CAN 的七项测试得出的严重程度评分显示,与其他参与者相比,CN 患者的测试项目发生变化的次数更多,得分更高,表明病情更为严重。我们建议在护理糖尿病患者时将该评分作为一种新工具,以识别最严重的 CAN。
{"title":"Cardiovascular autonomic neuropathy and charcot neuroarthropathy in type 2 diabetes: adding a new severity classification score","authors":"Jessica Castro de Vasconcelos, Yeelen Ballesteros Atala, Denise Engelbrecht Zantut-Wittmann, Maria Cândida Ribeiro Parisi","doi":"10.1007/s13410-024-01328-2","DOIUrl":"https://doi.org/10.1007/s13410-024-01328-2","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Objective</h3><p>This study aimed to assess the presence and characteristics of cardiovascular autonomic neuropathy (CAN) in people with type 2 diabetes with and without Charcot neuroarthropathy (CN).</p><h3 data-test=\"abstract-sub-heading\">Background</h3><p>Diabetes can affect nerves in many ways beyond sensitive neuropathy.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>A cross-sectional study was carried out in people with diabetes and CN who were matched for sex and age with two groups of people with diabetes without CN. All subjects underwent CAN assessment with seven tests (four Ewing tests and three bands of spectral analysis), and a severity score was constructed using these seven tests (each altered test equivalent to 1 point).</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Of the 69 people evaluated, 49 (71%) had incipient or installed CAN. A total of 95.2% of people with Charcot neuroarthropathy had incipient or installed CAN. There was a higher prevalence of dyslipidemia among people with installed autonomic neuropathy than among those with incipient CAN or without CAN. Thirty-four (69%) people with CAN had increased urinary albumin excretion. The severity score, constructed from the seven tests used for the diagnosis of CAN, revealed a greater number of altered tests and higher scores among people with CN when compared to the other participants, indicating greater severity of the condition.</p><h3 data-test=\"abstract-sub-heading\">Conclusions</h3><p>There is a high prevalence of CAN in people with type 2 diabetes followed in a tertiary health service and the use of severity score may enable to differentiate people with or without CN. We suggest that this score could be used as a new tool in caring for people with diabetes to identify the most severe CAN.</p>","PeriodicalId":50328,"journal":{"name":"International Journal of Diabetes in Developing Countries","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140097519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Self reported hypoglycemia in patients with type 2 diabetes mellitus taking oral anti-diabetics 服用口服抗糖尿病药物的 2 型糖尿病患者自我报告的低血糖情况
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2024-03-09 DOI: 10.1007/s13410-024-01326-4
Mahak Golani, Sanjay Pandit, Sumeet Singla

Objective

To determine the proportion of patients of type 2 Diabetes taking oral antidiabetics with self reported hypoglycemia and its causes.

Background

Hypoglycemia, an acute complication of diabetes mellitus is not only responsible for recurrent morbidity but also can lead to permanent brain damage or fatality if not recognized and treated in time. Also, hypoglycemia prevents achieving glycemic targets in diabetic patients.

Methods

Cross-sectional observation study of 70 patients of type 2 diabetes on oral anti-diabetics was conducted at Lok Nayak Hospital to determine the proportion of patients with self reported hypoglycemia and also to find out the various causes of hypoglycemia by subjecting them to a structured questionnaire. Hypoglycemia was considered when patient experienced at least one symptom, at least 2–3 times in last one month and symptom(s) were relieved by consuming sugar/meal.

Results

38.6% of the study subjects had hypoglycemia, out of which 92.59% patients had symptomatic hypoglycemia. Out of the patients experiencing hypoglycemia, 32% had severe episodes, 12% visited the hospital and 48% had more than 5 episodes per month. Dizziness was the commonest reported symptom (64%), followed by palpitations (52%). Attributed causes of hypoglycemia were missing meal (64%), drugs other than oral anti-diabetics (44%), sulfonylureas (44.2% in patients taking vs. 26.9% in patients not taking sulfonylurea), comorbidities (41% with vs. 22.4% without comorbidities) and lower socioeconomic status. One-third of patients experiencing were checking blood glucose levels during the symptoms. Highest prevalence of hypoglycemia was seen with HbA1c < 6.5% (p-value 0.04 when compared with subjects with HbA1c ≥ 6.5%), followed by ≥ 8% and least in 6.5–7.9%.

Conclusions

Lower prevalence of hypoglycemia in our study compared to other similar studies could be because of non-inclusion of patients on insulin in our study. High prevalence of multiple episodes justify the fact that hypoglycemia begets hypoglycemia. Hypoglycemia progressively increased as socioeconomic status changed from higher to lower, possibly due to non-availability of glucometer and lack of information. U-shaped correlation of hypoglycemic events was found with HbA1c levels.

背景低血糖是糖尿病的一种急性并发症,不仅会导致反复发病,如果不能及时发现和治疗,还可能导致永久性脑损伤或死亡。此外,低血糖也会阻碍糖尿病患者实现血糖目标。方法 在 Lok Nayak 医院对 70 名口服抗糖尿病药物的 2 型糖尿病患者进行了横断面观察研究,以确定自我报告低血糖的患者比例,并通过结构化问卷调查找出导致低血糖的各种原因。如果患者在过去一个月内至少出现过 2-3 次低血糖症状,且吃糖/餐后症状有所缓解,则视为低血糖。在发生低血糖的患者中,32%的患者病情严重,12%的患者曾去医院就诊,48%的患者每月发生低血糖超过 5 次。头晕是最常见的症状(64%),其次是心悸(52%)。导致低血糖的原因有:错过进餐时间(64%)、口服抗糖尿病药物以外的药物(44%)、磺脲类药物(服用磺脲类药物的患者为 44.2%,未服用磺脲类药物的患者为 26.9%)、合并症(有合并症的患者为 41%,无合并症的患者为 22.4%)和社会经济地位较低。三分之一的患者在出现症状时会检查血糖水平。HbA1c < 6.5%的低血糖发生率最高(与 HbA1c ≥ 6.5% 的受试者相比,P 值为 0.04),其次是 ≥ 8%,最低为 6.5-7.9%。多次发作的高发病率证明了低血糖会导致低血糖这一事实。随着社会经济地位从高到低的变化,低血糖的发生率也逐渐增加,这可能是由于没有血糖仪和缺乏信息造成的。低血糖事件与 HbA1c 水平呈 U 型相关。
{"title":"Self reported hypoglycemia in patients with type 2 diabetes mellitus taking oral anti-diabetics","authors":"Mahak Golani, Sanjay Pandit, Sumeet Singla","doi":"10.1007/s13410-024-01326-4","DOIUrl":"https://doi.org/10.1007/s13410-024-01326-4","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Objective</h3><p>To determine the proportion of patients of type 2 Diabetes taking oral antidiabetics with self reported hypoglycemia and its causes.</p><h3 data-test=\"abstract-sub-heading\">Background</h3><p>Hypoglycemia, an acute complication of diabetes mellitus is not only responsible for recurrent morbidity but also can lead to permanent brain damage or fatality if not recognized and treated in time. Also, hypoglycemia prevents achieving glycemic targets in diabetic patients.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>Cross-sectional observation study of 70 patients of type 2 diabetes on oral anti-diabetics was conducted at Lok Nayak Hospital to determine the proportion of patients with self reported hypoglycemia and also to find out the various causes of hypoglycemia by subjecting them to a structured questionnaire. Hypoglycemia was considered when patient experienced at least one symptom, at least 2–3 times in last one month and symptom(s) were relieved by consuming sugar/meal.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>38.6% of the study subjects had hypoglycemia, out of which 92.59% patients had symptomatic hypoglycemia. Out of the patients experiencing hypoglycemia, 32% had severe episodes, 12% visited the hospital and 48% had more than 5 episodes per month. Dizziness was the commonest reported symptom (64%), followed by palpitations (52%). Attributed causes of hypoglycemia were missing meal (64%), drugs other than oral anti-diabetics (44%), sulfonylureas (44.2% in patients taking vs. 26.9% in patients not taking sulfonylurea), comorbidities (41% with vs. 22.4% without comorbidities) and lower socioeconomic status. One-third of patients experiencing were checking blood glucose levels during the symptoms. Highest prevalence of hypoglycemia was seen with HbA<sub>1c</sub> &lt; 6.5% (<i>p</i>-value 0.04 when compared with subjects with HbA<sub>1c</sub> ≥ 6.5%), followed by ≥ 8% and least in 6.5–7.9%.</p><h3 data-test=\"abstract-sub-heading\">Conclusions</h3><p>Lower prevalence of hypoglycemia in our study compared to other similar studies could be because of non-inclusion of patients on insulin in our study. High prevalence of multiple episodes justify the fact that hypoglycemia begets hypoglycemia. Hypoglycemia progressively increased as socioeconomic status changed from higher to lower, possibly due to non-availability of glucometer and lack of information. U-shaped correlation of hypoglycemic events was found with HbA<sub>1c</sub> levels.</p>","PeriodicalId":50328,"journal":{"name":"International Journal of Diabetes in Developing Countries","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140097603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cluster analysis based on fasting and postprandial plasma glucose and insulin concentrations 基于空腹和餐后血浆葡萄糖和胰岛素浓度的聚类分析
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2024-03-07 DOI: 10.1007/s13410-024-01322-8
Miguel Altuve, Erika Severeyn

Objective

Plasma glucose and insulin concentrations are clinical markers used to diagnose metabolic diseases, particularly prediabetes and diabetes. In this paper, we conducted a cluster analysis using plasma glucose and insulin data collected during both fasting and 2-h postprandial periods.

Methods

Different clustering experiments were performed by changing the attributes, from one (fasting glucose) to four (fasting and postprandial glucose and insulin) attributes input to a k-means clustering algorithm. Based on the elbow and silhouette methods, three clusters were chosen to perform the clustering experiments. The Pearson correlation coefficient was utilized to evaluate the association between the levels of glucose and insulin within each created cluster.

Results

Results show that one cluster comprised individuals with prediabetes, another cluster consisted of individuals with diabetes, while subjects without prediabetes and diabetes were assigned to a separate cluster. Despite not being used as an attribute, we observed varying age ranges among subjects in the three clusters. Furthermore, significant correlations were found between fasting and postprandial insulin levels, as well as between fasting and postprandial glucose levels, suggesting a consistent relationship between these variables, and highlighting their interdependence in the context of glucose metabolism.

Conclusion

The clustering analysis successfully differentiated individuals into distinct clusters based on their metabolic conditions, confirming that the approach effectively captured the underlying patterns in the plasma glucose and insulin data. Furthermore, despite not being a considered attribute, the varying age ranges observed within the clusters indicate that age may play a role in the development and progression of diabetes. Additionally, the fasting and postprandial associations in insulin and glucose levels exhibited greater strength in the cluster encompassing individuals with diabetes, where insulin production or action is compromised.

目的 血浆葡萄糖和胰岛素浓度是用于诊断代谢性疾病,尤其是糖尿病前期和糖尿病的临床指标。本文利用空腹和餐后 2 小时内采集的血浆葡萄糖和胰岛素数据进行了聚类分析。方法通过改变输入 k-means 聚类算法的属性,从一个属性(空腹葡萄糖)到四个属性(空腹和餐后葡萄糖和胰岛素),进行了不同的聚类实验。根据肘法和剪影法,选择了三个聚类来进行聚类实验。结果显示,一个聚类由糖尿病前期患者组成,另一个聚类由糖尿病患者组成,而没有糖尿病前期和糖尿病的受试者被分配到一个单独的聚类中。尽管没有将年龄作为一个属性,但我们观察到三个群组中的受试者年龄范围各不相同。此外,我们还发现空腹和餐后胰岛素水平之间以及空腹和餐后葡萄糖水平之间存在明显的相关性,这表明这些变量之间存在一致的关系,并突出了它们在葡萄糖代谢中的相互依存性。此外,尽管年龄并非考虑的属性,但在聚类中观察到的不同年龄范围表明,年龄可能在糖尿病的发生和发展过程中起着一定的作用。此外,空腹和餐后胰岛素与血糖水平的关联在包括糖尿病患者的群组中表现得更为明显,因为糖尿病患者的胰岛素分泌或作用受到影响。
{"title":"Cluster analysis based on fasting and postprandial plasma glucose and insulin concentrations","authors":"Miguel Altuve, Erika Severeyn","doi":"10.1007/s13410-024-01322-8","DOIUrl":"https://doi.org/10.1007/s13410-024-01322-8","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Objective</h3><p>Plasma glucose and insulin concentrations are clinical markers used to diagnose metabolic diseases, particularly prediabetes and diabetes. In this paper, we conducted a cluster analysis using plasma glucose and insulin data collected during both fasting and 2-h postprandial periods.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>Different clustering experiments were performed by changing the attributes, from one (fasting glucose) to four (fasting and postprandial glucose and insulin) attributes input to a k-means clustering algorithm. Based on the elbow and silhouette methods, three clusters were chosen to perform the clustering experiments. The Pearson correlation coefficient was utilized to evaluate the association between the levels of glucose and insulin within each created cluster.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Results show that one cluster comprised individuals with prediabetes, another cluster consisted of individuals with diabetes, while subjects without prediabetes and diabetes were assigned to a separate cluster. Despite not being used as an attribute, we observed varying age ranges among subjects in the three clusters. Furthermore, significant correlations were found between fasting and postprandial insulin levels, as well as between fasting and postprandial glucose levels, suggesting a consistent relationship between these variables, and highlighting their interdependence in the context of glucose metabolism.</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>The clustering analysis successfully differentiated individuals into distinct clusters based on their metabolic conditions, confirming that the approach effectively captured the underlying patterns in the plasma glucose and insulin data. Furthermore, despite not being a considered attribute, the varying age ranges observed within the clusters indicate that age may play a role in the development and progression of diabetes. Additionally, the fasting and postprandial associations in insulin and glucose levels exhibited greater strength in the cluster encompassing individuals with diabetes, where insulin production or action is compromised.</p>","PeriodicalId":50328,"journal":{"name":"International Journal of Diabetes in Developing Countries","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140054557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The relationship between glycated hemoglobin (HbA1c), hematocrit, mean platelet volume, total white blood cell counts, Visceral Adiposity Index, and Systematic Coronary Risk Evaluation 2 (SCORE2) in patients without diabetes 非糖尿病患者的糖化血红蛋白 (HbA1c)、血细胞比容、平均血小板体积、白细胞总数、内脏脂肪指数和系统性冠状动脉风险评估 2 (SCORE2) 之间的关系
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2024-03-07 DOI: 10.1007/s13410-024-01325-5
Cem Yesiloglu, Canan Emiroglu, Cenk Aypak

Objective

Cardiovascular diseases (CVD) are the most common, deadly, noncommunicable disease group globally. This study aims to investigate the relationship between Systematic Coronary Risk Evaluation 2 (SCORE2) scores, which indicate the risk of future CVD in patients without known CVD and diabetes mellitus (DM) diagnoses, and HbA1c values.

Methods

In our retrospective cross-sectional study, patients under 40 years of age and over 69 years, those with a history of any CVD, those with a history of type 1 or type 2 DM, individuals with known anemia, patients using antihyperlipidemic or antidiabetic medications, and those with HbA1c levels of 6.5 and above were excluded. The relationship between the SCORE2 risk scores and related parameters was investigated among the included 249 patients.

Results

Among a total of 249 patients, with a mean age of 51.9 ± 7.5 years, 137 (55.0%) were male. Positive correlations were found between the SCORE2 (%) value of the patients and hemoglobin (rho = 0.222; p < 0.001), red blood cell (rho = 0.207; p = 0.001), hematocrit (rho = 0.267; p < 0.001), white blood cell (rho = 0.147; p = 0.021), triglyceride (rho = 0.247; p = 0.004), glucose (rho = 0.244; p < 0.001), HbA1c (rho = 0.208; p < 0.001), waist circumference (rho = 0.204; p = 0.001), and Visceral Adiposity Index (VAI) (rho = 0.145; p = 0.023) values.

Conclusion

A significant relationship was found between HbA1c and the current CVD risk score, SCORE2, in our patient group without DM. Our study is the first to examine this relationship in the literature. While no relationship was found between SCORE2 and body mass index (BMI), a significant relationship was found with the VAI. This indicates that CVD risk is more associated with visceral fat accumulation than total weight. Evaluating patients with normal BMI based on VAI will be beneficial in demonstrating CVD risk.

目的心血管疾病(CVD)是全球最常见、最致命的非传染性疾病。本研究旨在探讨系统冠状动脉风险评估 2(SCORE2)评分与 HbA1c 值之间的关系,SCORE2 评分表明未确诊心血管疾病和糖尿病(DM)的患者未来罹患心血管疾病的风险。方法在我们的回顾性横断面研究中,年龄在 40 岁以下和 69 岁以上的患者、有任何心血管疾病病史的患者、有 1 型或 2 型糖尿病病史的患者、已知贫血的患者、使用降血脂或抗糖尿病药物的患者以及 HbA1c 水平在 6.5 及以上的患者均被排除在外。结果249名患者中,男性137人(55.0%),平均年龄(51.9±7.5)岁。患者的 SCORE2(%)值与血红蛋白(rho = 0.222;p <;0.001)、红细胞(rho = 0.207;p = 0.001)、血细胞比容(rho = 0.267;p <;0.001)、白细胞(rho = 0.147;p = 0.021)、甘油三酯(rho = 0.247;p = 0.004)、血糖(rho = 0.244; p < 0.001)、HbA1c(rho = 0.208; p < 0.001)、腰围(rho = 0.204; p = 0.001)和内脏脂肪指数(VAI)(rho = 0.145; p = 0.023)值。我们的研究是首次在文献中研究这种关系。虽然未发现 SCORE2 与体重指数 (BMI) 之间有任何关系,但发现与 VAI 有显著关系。这表明心血管疾病风险与内脏脂肪堆积的关系比与总重量的关系更为密切。根据 VAI 对体重指数正常的患者进行评估将有利于显示心血管疾病风险。
{"title":"The relationship between glycated hemoglobin (HbA1c), hematocrit, mean platelet volume, total white blood cell counts, Visceral Adiposity Index, and Systematic Coronary Risk Evaluation 2 (SCORE2) in patients without diabetes","authors":"Cem Yesiloglu, Canan Emiroglu, Cenk Aypak","doi":"10.1007/s13410-024-01325-5","DOIUrl":"https://doi.org/10.1007/s13410-024-01325-5","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Objective</h3><p>Cardiovascular diseases (CVD) are the most common, deadly, noncommunicable disease group globally. This study aims to investigate the relationship between Systematic Coronary Risk Evaluation 2 (SCORE2) scores, which indicate the risk of future CVD in patients without known CVD and diabetes mellitus (DM) diagnoses, and HbA1c values.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>In our retrospective cross-sectional study, patients under 40 years of age and over 69 years, those with a history of any CVD, those with a history of type 1 or type 2 DM, individuals with known anemia, patients using antihyperlipidemic or antidiabetic medications, and those with HbA1c levels of 6.5 and above were excluded. The relationship between the SCORE2 risk scores and related parameters was investigated among the included 249 patients.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Among a total of 249 patients, with a mean age of 51.9 ± 7.5 years, 137 (55.0%) were male. Positive correlations were found between the SCORE2 (%) value of the patients and hemoglobin (rho = 0.222; <i>p</i> &lt; 0.001), red blood cell (rho = 0.207; <i>p</i> = 0.001), hematocrit (rho = 0.267; <i>p</i> &lt; 0.001), white blood cell (rho = 0.147; <i>p</i> = 0.021), triglyceride (rho = 0.247; <i>p</i> = 0.004), glucose (rho = 0.244; <i>p</i> &lt; 0.001), HbA1c (rho = 0.208; <i>p</i> &lt; 0.001), waist circumference (rho = 0.204; <i>p</i> = 0.001), and Visceral Adiposity Index (VAI) (rho = 0.145; <i>p</i> = 0.023) values.</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>A significant relationship was found between HbA1c and the current CVD risk score, SCORE2, in our patient group without DM. Our study is the first to examine this relationship in the literature. While no relationship was found between SCORE2 and body mass index (BMI), a significant relationship was found with the VAI. This indicates that CVD risk is more associated with visceral fat accumulation than total weight. Evaluating patients with normal BMI based on VAI will be beneficial in demonstrating CVD risk.</p>","PeriodicalId":50328,"journal":{"name":"International Journal of Diabetes in Developing Countries","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140054554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of rosuvastatin on sortilin and fetuin-A in type 2 diabetic patients: a randomized controlled trial 罗伐他汀对 2 型糖尿病患者体内索西林和胎儿素-A 的影响:随机对照试验
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2024-03-02 DOI: 10.1007/s13410-024-01324-6

Abstract

Objective

Rosuvastatin is a drug used for decreasing the risk of cardiovascular complications in type 2 diabetes mellitus (T2DM) patients. It is hypothesized that fetuin-A encourages lipid-induced insulin resistance and sortilin may increase the risk of atherosclerotic-related disorders. The aim of this study is to investigate the safety and efficacy of rosuvastatin co-treatment in T2DM patients and its effect on levels of sortilin and fetuin-A.

Methods

Seventy T2DM patients treated with glimepiride and metformin were randomly assigned to either co-treated with rosuvastatin 10 mg tablets (rosuvastatin group, n = 40), or placebo (placebo group, n = 30) daily for 3 months in a parallel, double-blind randomized controlled trial. Blood was collected for biochemical analysis. Serum sortilin and fetuin-A levels, glycemic and lipid profiles were measured before and 3 months after intervention.

Results

Fasting blood glucose (FBG, mg/dl) significantly decreased in placebo and rousvastatin groups from (104 ± 7.24 to 96.67 ± 7.14 vs 102.8 ± 6.43 to 93.0 ± 4.71), respectively, compared with baseline (p < 0.05). BMI and HbA1c decreased in placebo vs rosuvastatin group (29.20 ± 3.18 to 28.10 ± 3.08, p=0.08 vs 28.67 ± 3.56 to 27.66 ± 3.16, = 0.27), and (6.59 ± 0.27 to 6.36 ± 0.27 vs 6.56 ± 0.26 to 6.29 ± 0.25), respectively, compared with baseline (p ≤ 0.001) with no significance difference between both groups (p = 0.58 and = 0.25, respectively). Sortilin and fetuin-A levels significantly decreased in rosuvastatin vs placebo group from (1.77 ± 0.41 to 0.64 ± 0.37 vs 1.70 ± 0.36 to 1.65 ± 0.36) and from (295.33 ± 52.04 to 179.75 ± 60.22 vs 307.22 ± 50.11 to 288.94 ± 49.53), respectively, compared with baseline with significance difference between both groups (p < 0.001) compared with placebo. Significant positive correlation was found between sortilin with fetuin-A, low-density lipoprotein (LDL-C), and atherogenic index (p < 0.001). Significant positive correlation was observed between fetuin-A with FBG (p < 0.05) and atherogenic index (p < 0.001).

Conclusion

Rosuvastatin co-treatment in T2DM patients improves glycemic control and aids in decreasing the atherogenic biomarkers sortilin and fetuin-A levels, so it can be considered tolerable and efficient in improving lipid profile and atherogenic index.

Trial registration

ClinicalTrials.gov identifier (NCT number): NCT03907423, (The registration date: April 9, 2019). https://clinicaltrials.gov/ct2/show/NCT03907423.

摘要 目的 瑞舒伐他汀是一种用于降低 2 型糖尿病(T2DM)患者心血管并发症风险的药物。据推测,胎盘素-A 会促进脂质诱导的胰岛素抵抗,而索西林可能会增加动脉粥样硬化相关疾病的风险。本研究旨在探讨罗伐他汀联合治疗 T2DM 患者的安全性和有效性,以及其对索利林和非图因-A 水平的影响。 方法 在一项平行、双盲随机对照试验中,70 名接受格列美脲和二甲双胍治疗的 T2DM 患者被随机分配到每天同时服用罗伐他汀 10 毫克片剂(罗伐他汀组,n = 40)或安慰剂(安慰剂组,n = 30),为期 3 个月。采集血液进行生化分析。测量干预前和干预后 3 个月的血清索西林和胎盘素-A 水平、血糖和血脂状况。 结果 与基线相比,安慰剂组和芦伐他汀组的空腹血糖(FBG,mg/dl)分别从(104 ± 7.24降至96.67 ± 7.14 vs 102.8 ± 6.43降至93.0 ± 4.71)显著下降(p < 0.05)。安慰剂组与罗伐他汀组相比,BMI 和 HbA1c 均有所下降(29.20 ± 3.18 至 28.10 ± 3.08,p=0.08 vs 28.67 ± 3.56 至 27.66 ± 3.16,p = 0.27);罗伐他汀组与安慰剂组相比,BMI 和 HbA1c 均有所下降(6.59 ± 0.27 至 6.36 ± 0.27 vs 6.56 ± 0.26 to 6.29 ± 0.25),与基线相比(p ≤ 0.001),两组间差异无显著性(分别为 p = 0.58 和 p = 0.25)。与安慰剂组相比,罗伐他汀组的索替林和fetuin-A水平与基线相比分别从(1.77 ± 0.41 至 0.64 ± 0.37 vs 1.70 ± 0.36 至 1.65 ± 0.36)和(295.33 ± 52.04 至 179.75 ± 60.22 vs 307.22 ± 50.11 至 288.94 ± 49.53)显著下降,两组间差异显著(p <0.001)。发现索西林与胎脂素-A、低密度脂蛋白(LDL-C)和动脉粥样硬化指数之间存在显著的正相关性(p < 0.001)。胎儿素-A 与 FBG(p < 0.05)和致动脉粥样硬化指数(p < 0.001)呈显著正相关。 结论 瑞舒伐他汀联合治疗 T2DM 患者可改善血糖控制,并有助于降低致动脉粥样硬化生物标志物索斯替林和菲妥因-A 的水平,因此可被认为是可耐受的,并能有效改善血脂状况和致动脉粥样硬化指数。 试验注册 ClinicalTrials.gov 标识符(NCT 编号):NCT03907423,(注册日期:2019年4月9日)。https://clinicaltrials.gov/ct2/show/NCT03907423。
{"title":"Effect of rosuvastatin on sortilin and fetuin-A in type 2 diabetic patients: a randomized controlled trial","authors":"","doi":"10.1007/s13410-024-01324-6","DOIUrl":"https://doi.org/10.1007/s13410-024-01324-6","url":null,"abstract":"<h3>Abstract</h3> <span> <h3>Objective</h3> <p>Rosuvastatin is a drug used for decreasing the risk of cardiovascular complications in type 2 diabetes mellitus (T2DM) patients. It is hypothesized that fetuin-A encourages lipid-induced insulin resistance and sortilin may increase the risk of atherosclerotic-related disorders. The aim of this study is to investigate the safety and efficacy of rosuvastatin co-treatment in T2DM patients and its effect on levels of sortilin and fetuin-A.</p> </span> <span> <h3>Methods</h3> <p>Seventy T2DM patients treated with glimepiride and metformin were randomly assigned to either co-treated with rosuvastatin 10 mg tablets (rosuvastatin group, <em>n</em> = 40), or placebo (placebo group, <em>n</em> = 30) daily for 3 months in a parallel, double-blind randomized controlled trial. Blood was collected for biochemical analysis. Serum sortilin and fetuin-A levels, glycemic and lipid profiles were measured before and 3 months after intervention.</p> </span> <span> <h3>Results</h3> <p>Fasting blood glucose (FBG, mg/dl) significantly decreased in placebo and rousvastatin groups from (104 ± 7.24 to 96.67 ± 7.14 vs 102.8 ± 6.43 to 93.0 ± 4.71), respectively, compared with baseline (<em>p</em> &lt; 0.05). BMI and HbA1c decreased in placebo vs rosuvastatin group (29.20 ± 3.18 to 28.10 ± 3.08, p=0.08 vs 28.67 ± 3.56 to 27.66 ± 3.16, <em>p </em>= 0.27), and (6.59 ± 0.27 to 6.36 ± 0.27 vs 6.56 ± 0.26 to 6.29 ± 0.25), respectively, compared with baseline (<em>p</em> ≤ 0.001) with no significance difference between both groups (<em>p</em> = 0.58 and <em>p </em>= 0.25, respectively). Sortilin and fetuin-A levels significantly decreased in rosuvastatin vs placebo group from (1.77 ± 0.41 to 0.64 ± 0.37 vs 1.70 ± 0.36 to 1.65 ± 0.36) and from (295.33 ± 52.04 to 179.75 ± 60.22 vs 307.22 ± 50.11 to 288.94 ± 49.53), respectively, compared with baseline with significance difference between both groups (<em>p</em> &lt; 0.001) compared with placebo. Significant positive correlation was found between sortilin with fetuin-A, low-density lipoprotein (LDL-C), and atherogenic index (<em>p</em> &lt; 0.001). Significant positive correlation was observed between fetuin-A with FBG (<em>p</em> &lt; 0.05) and atherogenic index (<em>p</em> &lt; 0.001).</p> </span> <span> <h3>Conclusion</h3> <p>Rosuvastatin co-treatment in T2DM patients improves glycemic control and aids in decreasing the atherogenic biomarkers sortilin and fetuin-A levels, so it can be considered tolerable and efficient in improving lipid profile and atherogenic index.</p> </span> <span> <h3>Trial registration</h3> <p>ClinicalTrials.gov identifier (NCT number): <strong>NCT03907423, (The registration date: April 9, 2019). </strong>https://clinicaltrials.gov/ct2/show/NCT03907423<strong>.</strong></p> </span>","PeriodicalId":50328,"journal":{"name":"International Journal of Diabetes in Developing Countries","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140017267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Decoding the mystery of non-nutritive sweeteners 破解非营养型甜味剂之谜
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2024-02-24 DOI: 10.1007/s13410-024-01323-7
Sachdev Meenakshi, Viswanathan Mohan

Background

This commentary explores the landscape of non-nutritive sweeteners, further delves into the historical trajectory and the contemporary surge in the consumption of non-nutritive sweeteners (NNS), along with the accompanying controversies concerning their safety.

Objective

The aim is to provide a comprehensive understanding of the influences of NNS, drawn from global studies and diverse perspectives.

Methods

The commentary synthesizes findings from global studies, notably the NutriNet-Santé cohort, exploring associations between specific NNS and health consequences such as cerebrovascular events and malignancies. Additionally, it examines the research on consequences of NNS on gut microbiota and explores concerns linked to gestational diabetes, fetal exposure, and health of the offspring.

Results

While caution is advised during pregnancy and fetal development due to potential risks, NNS show promise in weight management and short-term dietary goals when used cautiously in lower amounts. The commentary underscores the necessity for inclusive, long-term studies to guide evidence-driven policies and guidelines.

Conclusion

While the article underscores the complexities and debates surrounding non-nutritive sweeteners (NNS), it also sheds light on the positive aspects. In the Indian context, where the intake of sweeteners is relatively low and mainly limited to beverages (tea or coffee), NNS appear to be safe, but prudent use is advocated. The article emphasizes the value of public education on NNS usage and concludes that, overall, NNS are reasonably safe when consumed in moderation. Continued research is needed to elucidate their intricate effects on health and impact on global health outcomes.

Implications

The article concludes with clear guidelines for using NNS in India, highlighting the need for informed decision-making and ongoing research to elucidate their broader health consequences.

背景本评论探讨了非营养型甜味剂的现状,进一步深入研究了非营养型甜味剂(NNS)消费的历史轨迹和当代激增,以及伴随而来的有关其安全性的争议。此外,它还研究了 NNS 对肠道微生物群的影响,并探讨了与妊娠糖尿病、胎儿暴露和后代健康有关的问题。结果虽然由于潜在风险,建议在怀孕和胎儿发育期间谨慎使用 NNS,但如果谨慎使用较低量的 NNS,则有望达到体重管理和短期饮食目标。该评论强调,有必要开展全面、长期的研究,以指导以证据为导向的政策和指南。结论虽然文章强调了围绕非营养性甜味剂(NNS)的复杂性和争论,但也揭示了其积极的方面。在印度,甜味剂的摄入量相对较低,且主要限于饮料(茶或咖啡),因此非营养型甜味剂似乎是安全的,但提倡谨慎使用。文章强调了关于使用 NNS 的公众教育的价值,并得出结论:总体而言,适量摄入 NNS 是相当安全的。文章最后提出了在印度使用 NNS 的明确指导原则,强调了做出明智决策和持续研究以阐明 NNS 对健康的广泛影响的必要性。
{"title":"Decoding the mystery of non-nutritive sweeteners","authors":"Sachdev Meenakshi, Viswanathan Mohan","doi":"10.1007/s13410-024-01323-7","DOIUrl":"https://doi.org/10.1007/s13410-024-01323-7","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Background</h3><p>This commentary explores the landscape of non-nutritive sweeteners, further delves into the historical trajectory and the contemporary surge in the consumption of non-nutritive sweeteners (NNS), along with the accompanying controversies concerning their safety.</p><h3 data-test=\"abstract-sub-heading\">Objective</h3><p>The aim is to provide a comprehensive understanding of the influences of NNS, drawn from global studies and diverse perspectives.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>The commentary synthesizes findings from global studies, notably the NutriNet-Santé cohort, exploring associations between specific NNS and health consequences such as cerebrovascular events and malignancies. Additionally, it examines the research on consequences of NNS on gut microbiota and explores concerns linked to gestational diabetes, fetal exposure, and health of the offspring.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>While caution is advised during pregnancy and fetal development due to potential risks, NNS show promise in weight management and short-term dietary goals when used cautiously in lower amounts. The commentary underscores the necessity for inclusive, long-term studies to guide evidence-driven policies and guidelines.</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>While the article underscores the complexities and debates surrounding non-nutritive sweeteners (NNS), it also sheds light on the positive aspects. In the Indian context, where the intake of sweeteners is relatively low and mainly limited to beverages (tea or coffee), NNS appear to be safe, but prudent use is advocated. The article emphasizes the value of public education on NNS usage and concludes that, overall, NNS are reasonably safe when consumed in moderation. Continued research is needed to elucidate their intricate effects on health and impact on global health outcomes.</p><h3 data-test=\"abstract-sub-heading\">Implications</h3><p>The article concludes with clear guidelines for using NNS in India, highlighting the need for informed decision-making and ongoing research to elucidate their broader health consequences.</p>","PeriodicalId":50328,"journal":{"name":"International Journal of Diabetes in Developing Countries","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139954392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Examining risk factors for diabetic foot: assessing diabetes self-management in type 2 diabetes patients 检查糖尿病足的风险因素:评估 2 型糖尿病患者的糖尿病自我管理情况
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2024-02-22 DOI: 10.1007/s13410-024-01320-w
Veysel Ürekli, Egemen Tural, Akın Dayan

Objective

Poor sugar regulation heightens the risk of complications linked to type 2 diabetes mellitus, while the adoption of effective diabetes self-management strategies has been shown to mitigate these risks. The objective of the study was to investigate the risk factors for diabetic foot by evaluating diabetes self-management using the Diabetes Self-Management Scale in patients with type 2 diabetes mellitus with and without diabetic foot.

Methods

The study is a single-centre, prospective, cross-sectional study conducted between August 29, 2022 and November 29, 2022. A total of 133 patients who presented to the diabetes and diabetic foot outpatient clinic were selected using a simple random sampling method. In order to make the evaluation, the sociodemographic form and Diabetes Self-Management Scale has been used. Potential risk factors associated with the presence of diabetic foot were examined using multivariate logistic regression analysis. A significance level of p < 0.05 was considered statistically significant.

Results

The mean age of the patients was 60.35 years and 45.1% (60) of them were female. According to the results of the multivariate logistic regression analysis, having more than 12 years of education, receiving diabetes education, and having higher Diabetes Self-Management Scale total scores negatively predicted the presence of diabetic foot. On the other hand, the duration of diabetes, systolic blood pressure, and HbA1c levels positively predicted the presence of diabetic foot.

Conclusion

Effective diabetes self-management plays a crucial role in improving diabetes complications. Care should be taken regarding diabetic foot in patients who have difficulties in effective diabetes self-management, as well as those with high systolic blood pressure, high HbA1c levels, shorter total education duration, and longer duration of diabetes.

目的糖调节不良会增加 2 型糖尿病并发症的风险,而采取有效的糖尿病自我管理策略则可降低这些风险。本研究旨在通过使用糖尿病自我管理量表评估伴有和不伴有糖尿病足的 2 型糖尿病患者的糖尿病自我管理情况,从而调查糖尿病足的风险因素。方法本研究是一项单中心、前瞻性、横断面研究,于 2022 年 8 月 29 日至 2022 年 11 月 29 日期间进行。研究采用简单随机抽样法,共抽取了 133 名糖尿病和糖尿病足门诊患者。为了进行评估,采用了社会人口学表格和糖尿病自我管理量表。通过多变量逻辑回归分析,研究了与糖尿病足相关的潜在风险因素。结果患者的平均年龄为 60.35 岁,其中 45.1%(60 人)为女性。多变量逻辑回归分析结果显示,受教育年限超过 12 年、接受过糖尿病教育、糖尿病自我管理量表总分越高,对出现糖尿病足的预测越低。结论有效的糖尿病自我管理对改善糖尿病并发症起着至关重要的作用。对于难以有效进行糖尿病自我管理的患者,以及收缩压高、HbA1c 水平高、总受教育时间较短和糖尿病病程较长的患者,应注意糖尿病足的问题。
{"title":"Examining risk factors for diabetic foot: assessing diabetes self-management in type 2 diabetes patients","authors":"Veysel Ürekli, Egemen Tural, Akın Dayan","doi":"10.1007/s13410-024-01320-w","DOIUrl":"https://doi.org/10.1007/s13410-024-01320-w","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Objective</h3><p>Poor sugar regulation heightens the risk of complications linked to type 2 diabetes mellitus, while the adoption of effective diabetes self-management strategies has been shown to mitigate these risks. The objective of the study was to investigate the risk factors for diabetic foot by evaluating diabetes self-management using the Diabetes Self-Management Scale in patients with type 2 diabetes mellitus with and without diabetic foot.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>The study is a single-centre, prospective, cross-sectional study conducted between August 29, 2022 and November 29, 2022. A total of 133 patients who presented to the diabetes and diabetic foot outpatient clinic were selected using a simple random sampling method. In order to make the evaluation, the sociodemographic form and Diabetes Self-Management Scale has been used. Potential risk factors associated with the presence of diabetic foot were examined using multivariate logistic regression analysis. A significance level of <i>p</i> &lt; 0.05 was considered statistically significant.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>The mean age of the patients was 60.35 years and 45.1% (60) of them were female. According to the results of the multivariate logistic regression analysis, having more than 12 years of education, receiving diabetes education, and having higher Diabetes Self-Management Scale total scores negatively predicted the presence of diabetic foot. On the other hand, the duration of diabetes, systolic blood pressure, and HbA1c levels positively predicted the presence of diabetic foot.</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>Effective diabetes self-management plays a crucial role in improving diabetes complications. Care should be taken regarding diabetic foot in patients who have difficulties in effective diabetes self-management, as well as those with high systolic blood pressure, high HbA1c levels, shorter total education duration, and longer duration of diabetes.</p>","PeriodicalId":50328,"journal":{"name":"International Journal of Diabetes in Developing Countries","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139954333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A randomized, double-blind, active-controlled trial assessing the efficacy and safety of a fixed-dose combination (FDC) of MEtformin hydrochloride 1000 mg ER, SItagliptin phosphate 100 mg, and DApagliflozin propanediol 10 mg in Indian adults with type 2 diabetes: The MESIDA trial 一项随机、双盲、主动对照试验,评估了盐酸甲福明 1000 毫克 ER、磷酸西格列汀 100 毫克和 10 毫克帕格列非嗪丙二醇固定剂量复方制剂 (FDC) 在印度成年 2 型糖尿病患者中的疗效和安全性:MESIDA 试验
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2024-02-17 DOI: 10.1007/s13410-024-01321-9

Abstract

Objective

To assess the efficacy and safety of fixed-dose combinations (FDC) of triple-drug dapagliflozin, sitagliptin, and metformin (DSM) compared with FDC of two-drug sitagliptin and metformin (SM), in Indian adult patients with type 2 diabetes (T2D).

Methods

A multicentric, randomized, double-blind, active-controlled, Phase 3 study (CTRI/2021/10/037461) was conducted on 274 Indian adult patients with T2D. Patients were randomized (1:1) to receive either an FDC of triple-drug (n = 137) dapagliflozin propanediol 10 mg, sitagliptin phosphate 100 mg, and metformin hydrochloride 1000 mg extended-release (DSM) or FDC of two-drug (n = 137) sitagliptin phosphate 100 mg and metformin hydrochloride 1000 mg sustained-release (SM), for 16 weeks. The primary endpoint was a change in HbA1c, while the secondary endpoints were changes in fasting plasma glucose (FPG), postprandial glucose (PPG), body weight, and safety.

Results

Both DSM and SM FDCs reduced HbA1c significantly (-1.45% and -1.00%, respectively, both p < 0.0001), however, HbA1c lowering was superior with DSM (∆ -0.45%; p = 0.0005) compared to SM, at week 16. Similarly, both DSM and SM FDCs reduced FPG and PPG significantly, however, FPG (∆ -12.4 mg/dl; p = 0.003) and PPG reduction (∆ -18.45 mg/dl; p = 0.01) were significantly superior to DSM compared to SM, respectively. No significant reduction in body weight was observed between the two arms. Both FDCs were well tolerated.

Conclusion

FDC of DSM was superior to SM in reducing HbA1c, FPG, and PPG in Indian adults with T2D. Both triple and dual FDCs had optimal safety profiles.

摘要 目的 评估达帕格列净、西格列汀和二甲双胍三药固定剂量联合用药(FDC)与西格列汀和二甲双胍两药固定剂量联合用药(FDC)在印度成年 2 型糖尿病(T2D)患者中的疗效和安全性。 方法 对 274 名印度成年 2 型糖尿病患者进行了一项多中心、随机、双盲、主动对照 3 期研究(CTRI/2021/10/037461)。患者被随机分配(1:1)接受三联药物(n = 137)达帕格列嗪丙二醇 10 毫克、磷酸西格列汀 100 毫克和盐酸二甲双胍 1000 毫克缓释(DSM)的 FDC 或两联药物(n = 137)磷酸西格列汀 100 毫克和盐酸二甲双胍 1000 毫克缓释(SM)的 FDC,为期 16 周。主要终点是 HbA1c 的变化,次要终点是空腹血浆葡萄糖 (FPG)、餐后血糖 (PPG)、体重和安全性的变化。 结果 DSM 和 SM FDC 均能显著降低 HbA1c(分别为-1.45%和-1.00%,p 均为 0.0001),但在第 16 周时,DSM 的 HbA1c 降低效果优于 SM(∆ -0.45%; p = 0.0005)。同样,DSM 和 SM FDC 均能显著降低 FPG 和 PPG,但与 SM 相比,DSM 的 FPG 降幅(∆ -12.4 mg/dl;p = 0.003)和 PPG 降幅(∆ -18.45 mg/dl;p = 0.01)明显优于 SM。两组患者的体重均未出现明显降低。两种 FDC 的耐受性均良好。 结论 DSM 的 FDC 在降低印度成年 T2D 患者的 HbA1c、FPG 和 PPG 方面优于 SM。三联和双联 FDC 均具有最佳安全性。
{"title":"A randomized, double-blind, active-controlled trial assessing the efficacy and safety of a fixed-dose combination (FDC) of MEtformin hydrochloride 1000 mg ER, SItagliptin phosphate 100 mg, and DApagliflozin propanediol 10 mg in Indian adults with type 2 diabetes: The MESIDA trial","authors":"","doi":"10.1007/s13410-024-01321-9","DOIUrl":"https://doi.org/10.1007/s13410-024-01321-9","url":null,"abstract":"<h3>Abstract</h3> <span> <h3>Objective</h3> <p>To assess the efficacy and safety of fixed-dose combinations (FDC) of triple-drug dapagliflozin, sitagliptin, and metformin (DSM) compared with FDC of two-drug sitagliptin and metformin (SM), in Indian adult patients with type 2 diabetes (T2D).</p> </span> <span> <h3>Methods</h3> <p>A multicentric, randomized, double-blind, active-controlled, Phase 3 study (CTRI/2021/10/037461) was conducted on 274 Indian adult patients with T2D. Patients were randomized (1:1) to receive either an FDC of triple-drug (<em>n</em> = 137) dapagliflozin propanediol 10 mg, sitagliptin phosphate 100 mg, and metformin hydrochloride 1000 mg extended-release (DSM) or FDC of two-drug (<em>n</em> = 137) sitagliptin phosphate 100 mg and metformin hydrochloride 1000 mg sustained-release (SM), for 16 weeks. The primary endpoint was a change in HbA1c, while the secondary endpoints were changes in fasting plasma glucose (FPG), postprandial glucose (PPG), body weight, and safety.</p> </span> <span> <h3>Results</h3> <p>Both DSM and SM FDCs reduced HbA1c significantly (-1.45% and -1.00%, respectively, both <em>p</em> &lt; 0.0001), however, HbA1c lowering was superior with DSM (∆ -0.45%; <em>p</em> = 0.0005) compared to SM, at week 16. Similarly, both DSM and SM FDCs reduced FPG and PPG significantly, however, FPG (∆ -12.4 mg/dl; <em>p</em> = 0.003) and PPG reduction (∆ -18.45 mg/dl; <em>p</em> = 0.01) were significantly superior to DSM compared to SM, respectively. No significant reduction in body weight was observed between the two arms. Both FDCs were well tolerated.</p> </span> <span> <h3>Conclusion</h3> <p>FDC of DSM was superior to SM in reducing HbA1c, FPG, and PPG in Indian adults with T2D. Both triple and dual FDCs had optimal safety profiles.</p> </span>","PeriodicalId":50328,"journal":{"name":"International Journal of Diabetes in Developing Countries","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139752192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corneal endothelial morphology changes in patients with proliferative diabetic retinopathy 增殖性糖尿病视网膜病变患者的角膜内皮形态变化
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2024-02-17 DOI: 10.1007/s13410-024-01318-4
Xiaoli Yu, Xiaojuan Chen, Lele Li, Min Wang, Lidan Xue, Yue Zhou, Lili Huang

Background

Diabetes patients often suffer from diabetes keratopathy in the course of their illness. The examination of corneal endothelium in proliferative diabetic retinopathy (PDR) patients has important clinical significance. Here, we investigated the effect of PDR on corneal endothelial parameters.

Objective

To analyze the associations between corneal endothelial cell parameters and proliferative diabetic retinopathy (PDR).

Methods

We analyzed endothelial cell density (ECD), coefficient of variation in cell size (CV), hexagonality, and neutrophil/lymphocyte ratio (NLR) in patients with PDR and compared them with age-matched controls. The influences of duration of diabetes mellitus and level of glycosylated hemoglobin (HbA1c) were also analyzed.

Results

The study group included 106 eyes of 106 PDR patients and 85 eyes of 85 control subjects. Significant differences were found in ECD (2,436.11 ± 222.08 cells/mm2 in PDR, 2527.16 ± 191.64 cells/mm2 in controls; p < 0.05), CV (41.32 ± 7.40 in PDR, 37.71 ± 5.08 in controls; p < 0.05), Hex (50.07 ± 5.32 in PDR patients, 53.29 ± 5.73 in controls; p < 0.05), and NLR (2.94 ± 1.27 in PDR, 2.12 ± 0.56 in controls; p < 0.05). In the PDR group, ECD showed a decreasing trend as age increased (p trend < 0.05), and Spearman’s correlation indicated a significant positive correlation between NLR and macular thickness (p < 0.05).

Conclusions

PDR had deleterious effects on the corneal endothelium. PDR patients should undergo a rigorous corneal assessment to analyze the status of endothelial health, to identify the optimal treatment.

背景糖尿病患者在患病期间常常会出现糖尿病角膜病变。对增殖性糖尿病视网膜病变(PDR)患者的角膜内皮进行检查具有重要的临床意义。方法 我们分析了增殖性糖尿病视网膜病变(PDR)患者的角膜内皮细胞密度(ECD)、细胞大小变异系数(CV)、六角形度和中性粒细胞/淋巴细胞比值(NLR),并与年龄匹配的对照组进行了比较。研究还分析了糖尿病持续时间和糖化血红蛋白(HbA1c)水平的影响。在 ECD(PDR 患者为 2,436.11 ± 222.08 个细胞/mm2,对照组为 2527.16 ± 191.64 个细胞/mm2;p < 0.05)、CV(PDR 患者为 41.32 ± 7.40 个细胞/mm2,对照组为 37.71 ± 5.08 个细胞/mm2;p < 0.05)、HbA1c(PDR 患者为 2,436.11 ± 222.08 个细胞/mm2,对照组为 2527.16 ± 191.64 个细胞/mm2。08;p <;0.05)、Hex(PDR 患者为 50.07 ± 5.32,对照组为 53.29 ± 5.73;p <;0.05)和 NLR(PDR 患者为 2.94 ± 1.27,对照组为 2.12 ± 0.56;p <;0.05)。结论PDR对角膜内皮有有害影响。PDR患者应接受严格的角膜评估,分析内皮健康状况,以确定最佳治疗方案。
{"title":"Corneal endothelial morphology changes in patients with proliferative diabetic retinopathy","authors":"Xiaoli Yu, Xiaojuan Chen, Lele Li, Min Wang, Lidan Xue, Yue Zhou, Lili Huang","doi":"10.1007/s13410-024-01318-4","DOIUrl":"https://doi.org/10.1007/s13410-024-01318-4","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Background </h3><p>Diabetes patients often suffer from diabetes keratopathy in the course of their illness. The examination of corneal endothelium in proliferative diabetic retinopathy (PDR) patients has important clinical significance. Here, we investigated the effect of PDR on corneal endothelial parameters.</p><h3 data-test=\"abstract-sub-heading\">Objective</h3><p>To analyze the associations between corneal endothelial cell parameters and proliferative diabetic retinopathy (PDR).</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>We analyzed endothelial cell density (ECD), coefficient of variation in cell size (CV), hexagonality, and neutrophil/lymphocyte ratio (NLR) in patients with PDR and compared them with age-matched controls. The influences of duration of diabetes mellitus and level of glycosylated hemoglobin (HbA1c) were also analyzed.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>The study group included 106 eyes of 106 PDR patients and 85 eyes of 85 control subjects. Significant differences were found in ECD (2,436.11 ± 222.08 cells/mm<sup>2</sup> in PDR, 2527.16 ± 191.64 cells/mm<sup>2</sup> in controls; <i>p</i> &lt; 0.05), CV (41.32 ± 7.40 in PDR, 37.71 ± 5.08 in controls; <i>p</i> &lt; 0.05), Hex (50.07 ± 5.32 in PDR patients, 53.29 ± 5.73 in controls; <i>p</i> &lt; 0.05), and NLR (2.94 ± 1.27 in PDR, 2.12 ± 0.56 in controls; <i>p</i> &lt; 0.05). In the PDR group, ECD showed a decreasing trend as age increased (<i>p</i> trend &lt; 0.05), and Spearman’s correlation indicated a significant positive correlation between NLR and macular thickness (<i>p</i> &lt; 0.05).</p><h3 data-test=\"abstract-sub-heading\">Conclusions</h3><p>PDR had deleterious effects on the corneal endothelium. PDR patients should undergo a rigorous corneal assessment to analyze the status of endothelial health, to identify the optimal treatment.</p>","PeriodicalId":50328,"journal":{"name":"International Journal of Diabetes in Developing Countries","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139752406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impacts of a 12-week aerobic, resistance, and combined exercise training on serum FAM19A5, glucose homeostasis, and novel cardiovascular risk factors among adults with obesity 为期 12 周的有氧、阻力和综合运动训练对肥胖症成人血清 FAM19A5、糖稳态和新型心血管风险因素的影响
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2024-02-07 DOI: 10.1007/s13410-024-01315-7
Ehsan Mir, Alireza Shamseddini, Najmeh Rahimi, Behzad Bazgir

Objective

To determine the impacts of 12 weeks of aerobic, resistance, or combined training on FAM19A5, glucose homeostasis, body composition, and physical performance in obese men.

Methods

Fifty-eight obese men [age = 49 ± 6 years; body mass index (BMI) = 29 ± 2 kg m−2] were randomly assigned to aerobic training (n = 14), resistance training (n = 15), combined training (n = 15), and control (n = 14) groups. Interventions were three sessions per week for 12 weeks.

Results

FAM19A5 levels remained unaltered in all three intervention groups. However, insulin concentrations, triglyceride, HOMA-IR, VAI, TyG, and fat% declined in all three interventions, whereas VO2max increased. In addition, glucose levels, LAP, body weight, and BMI were reduced in aerobic and combined groups, while systolic blood pressure was reduced in resistance and combined programs. We also observed a significant reduction in low-density lipoprotein following only combined exercises and a significant increase in high-density lipoprotein after only aerobic exercises. There was a significant negative relationship between serum levels of FAM19A5 and HOMA-IR.

Conclusion

This is the first report to assess the influence of exercise interventions on circulating FAM19A5 levels in obese adults. Although FAM19A5 levels remained unchanged in all three interventions, our work provides information to support that aerobic, resistance, and combined regimens can be effective in improving HOMA-IR, triglyceride, systolic blood pressure, BMI, and aerobic performance in obese men. Additional studies with large sample size should be conducted to further clarify the underlying mechanisms.

方法将 58 名肥胖男性[年龄 = 49 ± 6 岁;体重指数 (BMI) = 29 ± 2 kg m-2]随机分配到有氧训练组(n = 14)、阻力训练组(n = 15)、综合训练组(n = 15)和对照组(n = 14)。结果在所有三个干预组中,FAM19A5 的水平保持不变。然而,在所有三个干预组中,胰岛素浓度、甘油三酯、HOMA-IR、VAI、TyG 和脂肪率均有所下降,而最大氧饱和度则有所提高。此外,有氧组和综合组的血糖水平、LAP、体重和 BMI 均有所下降,而阻力组和综合组的收缩压有所下降。我们还观察到,只进行综合运动后,低密度脂蛋白显著降低,而只进行有氧运动后,高密度脂蛋白显著升高。结论这是第一份评估运动干预对肥胖成年人循环中 FAM19A5 水平影响的报告。虽然 FAM19A5 水平在所有三种干预措施中都保持不变,但我们的工作提供的信息支持了有氧、阻力和综合方案可有效改善肥胖男性的 HOMA-IR、甘油三酯、收缩压、体重指数和有氧表现。应进行更多的大样本研究,以进一步阐明其潜在机制。
{"title":"Impacts of a 12-week aerobic, resistance, and combined exercise training on serum FAM19A5, glucose homeostasis, and novel cardiovascular risk factors among adults with obesity","authors":"Ehsan Mir, Alireza Shamseddini, Najmeh Rahimi, Behzad Bazgir","doi":"10.1007/s13410-024-01315-7","DOIUrl":"https://doi.org/10.1007/s13410-024-01315-7","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Objective</h3><p>To determine the impacts of 12 weeks of aerobic, resistance, or combined training on FAM19A5, glucose homeostasis, body composition, and physical performance in obese men.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>Fifty-eight obese men [age = 49 ± 6 years; body mass index (BMI) = 29 ± 2 kg m<sup>−2</sup>] were randomly assigned to aerobic training (<i>n</i> = 14), resistance training (<i>n</i> = 15), combined training (<i>n</i> = 15), and control (<i>n</i> = 14) groups. Interventions were three sessions per week for 12 weeks.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>FAM19A5 levels remained unaltered in all three intervention groups. However, insulin concentrations, triglyceride, HOMA-IR, VAI, TyG, and fat% declined in all three interventions, whereas VO<sub>2max</sub> increased. In addition, glucose levels, LAP, body weight, and BMI were reduced in aerobic and combined groups, while systolic blood pressure was reduced in resistance and combined programs. We also observed a significant reduction in low-density lipoprotein following only combined exercises and a significant increase in high-density lipoprotein after only aerobic exercises. There was a significant negative relationship between serum levels of FAM19A5 and HOMA-IR.</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>This is the first report to assess the influence of exercise interventions on circulating FAM19A5 levels in obese adults. Although FAM19A5 levels remained unchanged in all three interventions, our work provides information to support that aerobic, resistance, and combined regimens can be effective in improving HOMA-IR, triglyceride, systolic blood pressure, BMI, and aerobic performance in obese men. Additional studies with large sample size should be conducted to further clarify the underlying mechanisms.</p>","PeriodicalId":50328,"journal":{"name":"International Journal of Diabetes in Developing Countries","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139752410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Diabetes in Developing Countries
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1